Literature DB >> 9041253

Complement activation after ischemia-reperfusion in human liver allografts: incidence and pathophysiological relevance.

J Y Scoazec1, G Borghi-Scoazec, F Durand, J Bernuau, B N Pham, J Belghiti, G Feldmann, C Degott.   

Abstract

BACKGROUND & AIMS: Little is known about the occurrence and possible consequences of local complement activation in human liver transplantation. The aim of this study was to search for signs of complement activation in human liver allografts and evaluate their relationship to cell injury and leukocyte sequestration.
METHODS: In 33 postreperfusion biopsy specimens, 9 preoperative specimens, and 10 intraoperative specimens, the cytolytic membrane attack complex of complement was localized, expression of complement inhibitors was evaluated, and intragraft accumulation of leukocytes and platelets was quantitated.
RESULTS: In control samples and preoperative biopsy specimens, the membrane attack complex was detected only in extracellular deposits, associated with its soluble inhibitors clusterin and vitronectin. Comparable observations were performed in 14 postoperative specimens. In the remaining 19 postoperative specimens, membrane attack complex decorated a variable proportion of hepatocytes. The extent of membrane attack complex deposition correlated with the increase in postoperative aspartate aminotransferase levels in serum (P = 0.002) and the decrease in postoperative factor V levels in serum (P = 0.002). It also correlated with the number of leukocytes and platelets accumulating within the graft (P < or = 0.001).
CONCLUSIONS: Local complement activation is frequent during human liver transplantation and probably contributes to cell injury and leukocyte sequestration in the allograft.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041253     DOI: 10.1053/gast.1997.v112.pm9041253

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

2.  Liver transplantation in man: morphometric analysis of the parenchymal alterations following cold ischaemia and warm ischaemia/reperfusion.

Authors:  L Vizzotto; M Vertemati; C T Degna; P Aseni
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

3.  The reduction rate of serum C3 following liver transplantation is an effective predictor of non-anastomotic strictures.

Authors:  Shuang Liu; Tonghai Xing; Tao Sheng; Shouwen Yang; Li Huang; Zhihai Peng; Xing Sun
Journal:  Hepatol Int       Date:  2014-03-06       Impact factor: 6.047

4.  Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver.

Authors:  L Bergamaschini; G Gobbo; S Gatti; L Caccamo; P Prato; M Maggioni; P Braidotti; R Di Stefano; L R Fassati
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 5.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

6.  Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report.

Authors:  Suk-Hee Park; Gaab-Soo Kim
Journal:  Korean J Anesthesiol       Date:  2014-06-26

7.  Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.

Authors:  Jeffrey M Saland; Benjamin L Shneider; Jonathan S Bromberg; Patricia A Shi; Stephen C Ward; Margret S Magid; Corinne Benchimol; Mouin G Seikaly; Sukru H Emre; Elena Bresin; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 8.237

Review 8.  Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function.

Authors:  Kelley Núñez; Paul Thevenot; Abeer Alfadhli; Ari Cohen
Journal:  Int J Mol Sci       Date:  2018-06-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.